95 related articles for article (PubMed ID: 8700143)
1. Structural requirements for G(o) activation by receptor-derived peptides: activation and modulation domains of the alpha 2-adrenergic receptor i3c region.
Wade SM; Scribner MK; Dalman HM; Taylor JM; Neubig RR
Mol Pharmacol; 1996 Aug; 50(2):351-8. PubMed ID: 8700143
[TBL] [Abstract][Full Text] [Related]
2. Multisite interactions of receptors and G proteins: enhanced potency of dimeric receptor peptides in modifying G protein function.
Wade SM; Dalman HM; Yang SZ; Neubig RR
Mol Pharmacol; 1994 Jun; 45(6):1191-7. PubMed ID: 8022412
[TBL] [Abstract][Full Text] [Related]
3. Identification of the critical domains of the delta-opioid receptor involved in G protein coupling using site-specific synthetic peptides.
Merkouris M; Dragatsis I; Megaritis G; Konidakis G; Zioudrou C; Milligan G; Georgoussi Z
Mol Pharmacol; 1996 Oct; 50(4):985-93. PubMed ID: 8863845
[TBL] [Abstract][Full Text] [Related]
4. Substitution of three amino acids switches receptor specificity of Gq alpha to that of Gi alpha.
Conklin BR; Farfel Z; Lustig KD; Julius D; Bourne HR
Nature; 1993 May; 363(6426):274-6. PubMed ID: 8387644
[TBL] [Abstract][Full Text] [Related]
5. alpha(2A)-adrenergic receptor derived peptide adsorbates: a G-protein interaction study.
Vahlberg C; Petoral RM; Lindell C; Broo K; Uvdal K
Langmuir; 2006 Aug; 22(17):7260-4. PubMed ID: 16893224
[TBL] [Abstract][Full Text] [Related]
6. Alkyl-substituted amino acid amides and analogous di- and triamines: new non-peptide G protein activators.
Leschke C; Storm R; Breitweg-Lehmann E; Exner T; Nürnberg B; Schunack W
J Med Chem; 1997 Sep; 40(19):3130-9. PubMed ID: 9301677
[TBL] [Abstract][Full Text] [Related]
7. Hydrophobicity of residue351 of the G protein Gi1 alpha determines the extent of activation by the alpha 2A-adrenoceptor.
Bahia DS; Wise A; Fanelli F; Lee M; Rees S; Milligan G
Biochemistry; 1998 Aug; 37(33):11555-62. PubMed ID: 9708991
[TBL] [Abstract][Full Text] [Related]
8. Gi-mediated translocation of GLUT4 is independent of p85/p110alpha and p110gamma phosphoinositide 3-kinases but might involve the activation of Akt kinase.
Wang L; Hayashi H; Kishi K; Huang L; Hagi A; Tamaoka K; Hawkins PT; Ebina Y
Biochem J; 2000 Feb; 345 Pt 3(Pt 3):543-55. PubMed ID: 10642513
[TBL] [Abstract][Full Text] [Related]
9. Thrombin receptor activation by thrombin and receptor-derived peptides in platelet and CHRF-288 cell membranes: receptor-stimulated GTPase and evaluation of agonists and partial agonists.
Seiler SM; Peluso M; Tuttle JG; Pryor K; Klimas C; Matsueda GR; Bernatowicz MS
Mol Pharmacol; 1996 Jan; 49(1):190-7. PubMed ID: 8569706
[TBL] [Abstract][Full Text] [Related]
10. A cysteine-3 to serine mutation of the G-protein Gi1 alpha abrogates functional activation by the alpha 2A-adrenoceptor but not interactions with the beta gamma complex.
Wise A; Grassie MA; Parenti M; Lee M; Rees S; Milligan G
Biochemistry; 1997 Sep; 36(35):10620-9. PubMed ID: 9271492
[TBL] [Abstract][Full Text] [Related]
11. Reciprocal modulation of alpha(2A)-adrenoceptor and G(alpha o) protein states as determined by carboxy-terminal mutagenesis of a G(alpha o) protein.
Wurch T; Okuda J; Pauwels PJ
Mol Pharmacol; 2001 Oct; 60(4):666-73. PubMed ID: 11562427
[TBL] [Abstract][Full Text] [Related]
12. G protein activation by human dopamine D3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5'-O-(3-[35S]thio)- triphosphate binding and antibody study.
Newman-Tancredi A; Cussac D; Audinot V; Pasteau V; Gavaudan S; Millan MJ
Mol Pharmacol; 1999 Mar; 55(3):564-74. PubMed ID: 10051542
[TBL] [Abstract][Full Text] [Related]
13. Role of the amino terminus of the third intracellular loop in agonist-promoted downregulation of the alpha2A-adrenergic receptor.
Jewell-Motz EA; Donnelly ET; Eason MG; Liggett SB
Biochemistry; 1997 Jul; 36(29):8858-63. PubMed ID: 9220972
[TBL] [Abstract][Full Text] [Related]
14. Activation of constitutive 5-hydroxytryptamine(1B) receptor by a series of mutations in the BBXXB motif: positioning of the third intracellular loop distal junction and its G(o)alpha protein interactions.
Pauwels PJ; Gouble A; Wurch T
Biochem J; 1999 Oct; 343 Pt 2(Pt 2):435-42. PubMed ID: 10510311
[TBL] [Abstract][Full Text] [Related]
15. Regulation of guanine nucleotide turnover on Gi/Go by agonist-stimulated and spontaneously active muscarinic receptors in cardiac membranes.
Quist E; Satumtira N; Vasan R
Arch Biochem Biophys; 1999 Jan; 361(1):57-64. PubMed ID: 9882428
[TBL] [Abstract][Full Text] [Related]
16. Regulation of G protein activation and effector modulation by fusion proteins between the human 5-hydroxytryptamine(1A) receptor and the alpha subunit of G(i1): differences in receptor-constitutive activity imparted by single amino acid substitutions in G(i1)alpha.
Kellett E; Carr IC; Milligan G
Mol Pharmacol; 1999 Oct; 56(4):684-92. PubMed ID: 10496950
[TBL] [Abstract][Full Text] [Related]
17. G protein amino-terminal alpha i2/alpha s chimeras reveal amino acids important in regulating alpha s activity.
Russell M; Johnson GL
Mol Pharmacol; 1993 Aug; 44(2):255-63. PubMed ID: 8394989
[TBL] [Abstract][Full Text] [Related]
18. PTH-dependent adenylyl cyclase activation in SaOS-2 cells: passage dependent effects on G protein interactions.
Gao H; Bodine PV; Murrills R; Bex FJ; Bilezikian JP; Morris SA
J Cell Physiol; 2002 Oct; 193(1):10-8. PubMed ID: 12209875
[TBL] [Abstract][Full Text] [Related]
19. Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A.
Daaka Y; Luttrell LM; Lefkowitz RJ
Nature; 1997 Nov; 390(6655):88-91. PubMed ID: 9363896
[TBL] [Abstract][Full Text] [Related]
20. A surface-exposed region of G(salpha) in which substitutions decrease receptor-mediated activation and increase receptor affinity.
Grishina G; Berlot CH
Mol Pharmacol; 2000 Jun; 57(6):1081-92. PubMed ID: 10825378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
